Drugstore operator CVS reported revenues in the group’s retail pharmacy segment increased 3.7% in the second quarter to $14.3bn (£9.7bn), with total same-store sales increasing 2.1% over the prior year.

Pharmacy same-store sales increased 2.9%, helped by continued growth of its Maintenance Choice prescription offer. Front store same-store sales increased 0.4%, hit by an earlier Easter and by comparison with sales during the H1N1 flu pandemic.

Operating profit in the segment rose slightly to $1.1bn (£744m).